欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
IS/H/0382/007
药品名称
Lenalidomid Aristo
活性成分
lenalidomide 25.0 mg
剂型
Capsule, hard
上市许可持有人
Aristo Pharma GmbH Wallenroderstr 8-10 13435 Berlin, Germany
参考成员国 - 产品名称
Iceland (IS)
Lenalidomid Aristo
互认成员国 - 产品名称
Spain (ES)
Italy (IT)
许可日期
2020/07/17
最近更新日期
2024/09/05
药物ATC编码
L04AX04 lenalidomide
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Product Information
|
common_combined_clean_from EoP sequence 24_07_2020
Date of last change:2024/09/06
Final PL
|
IS_H_0382_IB_008_009_PIL_Lenalidomid_Aristo_19_7_2022
Date of last change:2024/09/06
Final SPC
|
IS_H_0382_IB_008_009_SmPC_Lenalidomid_Aristo_19_7_2022
Date of last change:2024/09/06
Final Labelling
|
IS_H_0382_IB_008_labop_Lenalidomid_Aristo_10mg_19_7_2022
Date of last change:2024/09/06
Final Labelling
|
IS_H_0382_IB_008_labop_Lenalidomid_Aristo_15mg_19_7_2022
Date of last change:2024/09/06
Final Labelling
|
IS_H_0382_IB_008_labop_Lenalidomid_Aristo_2_5mg_19_7_2022
Date of last change:2024/09/06
Final Labelling
|
IS_H_0382_IB_008_labop_Lenalidomid_Aristo_20mg_19_7_2022
Date of last change:2024/09/06
Final Labelling
|
IS_H_0382_IB_008_labop_Lenalidomid_Aristo_25mg_19_7_2022
Date of last change:2024/09/06
Final Labelling
|
IS_H_0382_IB_008_labop_Lenalidomid_Aristo_5mg_19_7_2022
Date of last change:2024/09/06
Final Labelling
|
IS_H_0382_IB_008_labop_Lenalidomid_Aristo_7_5mg_19_7_2022
Date of last change:2024/09/06
PubAR
|
IS_H_0382_Lenalidomide_Aristo_001_007_PAR
Date of last change:2024/09/06
PubAR Summary
|
IS_H_0382_Lenalidomide_Aristo_001_007_PARsummary
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase